Chronic lymphocytic leukaemia trials in Germany

In Germany 37 Also abroad 308

37 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 11 November 2026. Ask the study team whether a trial fits you.

No phaseTaking people
Registry Platform Hematologic Malignancies (RUBIN) - Extension of Tumor Registry Lymphatic Neoplasms
Where
Freiburg im Breisgau
Age
18 years and over
People
2,950
Run by
iOMEDICO AG
See details and how to joinNCT06043011
Phase 3Taking people
Global Trial in APG2575 for Patients With CLL/SLL
Where
Dresden, Karlsruhe, Munich, Offenbach Am Main
Age
18 years to 99 years
People
400 worldwide
Run by
Ascentage Pharma Group Inc.
See details and how to joinNCT06104566 · EU 2023-508005-24-00
No phaseTaking people
A Prospective Observational Trial to Assess Treatment Sequences and Factors That Impact Overall Sur-vival in Patients With Chronic Lymphocytic Leukaemia (CLL) Treated Within First-line Studies of the GCLLSG
Where
Cologne, Ulm
Age
18 years to 99 years
People
2,000
Run by
German CLL Study Group
See details and how to joinNCT06792994
Phase 1Taking people
A first-in-human clinical study to assess safety and tolerability of genetically modified T-cells in ROR1 positive tumors
Where
Berlin, Cologne, Wuerzburg
Age
18 years and over
People
44
Run by
Universitaetsklinikum Wuerzburg AöR
See details and how to join2024-512019-36-00 · EU 2024-512019-36-00
No phaseTaking people
CLL-IMPACT: A Clinical Nutrition Trial Investigating Immune and Metabolic Changes in Early-Stage CLL
Where
München
Age
18 years and over
People
50
Run by
Technical University of Munich
See details and how to joinNCT07487428
Phase 1Enrolling by invitation
Long-Term Follow-Up of AvenCell Sponsored CAR-T Cell Clinical Trials
Where
Berlin, Dresden, Marburg, Munich, Ulm
Age
18 years and over
People
178
Run by
AvenCell Therapeutics, Inc.
See details and how to joinNCT07474051 · EU 2025-521717-67-00
Phase 2Taking people
Study to Assess Change in Disease Activity and Adverse Events of Oral Venetoclax With Intravenous (IV) Obinutuzumab in Adult Participants With Recurring Chronic Lymphocytic Leukemia (CLL)
Where
Berlin, Cologne, Dresden, Essen, Halle (Saale), Homburg, Kiel, Landshut, Mutlangen, Paderborn, Rostock, Ulm
Age
18 years and over
People
75 worldwide
Run by
AbbVie
See details and how to joinNCT04895436 · EU 2023-504599-10-00
No phaseTaking people
Transgene Assay Testing Service of Tumor Samples From Patients Who Received a Bristol-Myers Squibb Manufactured Gene Modified Cell Therapy and Have a Qualifying Second Primary Malignancy
Where
Essen
People
50 worldwide
Run by
Bristol-Myers Squibb
See details and how to joinNCT06357754
No phaseTaking people
Evaluation of Acute and Chronic Nephrotoxicity in Acute Lymphatic Leukemia Patients Using Ultrasound Localization Microscopy
Where
Erlangen
Age
3 years to 17 years
People
30
Run by
University of Erlangen-Nürnberg Medical School
See details and how to joinNCT07313878
No phaseTaking people
Registry of the German CLL Study Group
Where
Dresden
Age
18 years and over
People
8,000
Run by
German CLL Study Group
See details and how to joinNCT02863692
No phaseTaking people
Developing a Patient-Reported Outcome (PRO) Screening Measure for Infections and Measuring Quality of Life in Hematological Patients With Secondary Immunodeficiency (SID) Across the Treatment Trajectory - The PRO SID Project
Where
Berlin, Garmisch-Partenkirchen
Age
18 years and over
People
120 worldwide
Run by
Medical University Innsbruck
See details and how to joinNCT06821880
Phase 1/2Taking people
Treatment of Patients With Relapsed or Refractory CD19+ Lymphoid Disease With T Cells Expressing a Third-generation CAR
Where
Heidelberg
Age
3 years and over
People
68
Run by
University Hospital Heidelberg
See details and how to joinNCT03676504 · EU 2024-516832-82-00